These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 26888921)

  • 1. Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy.
    Mazzaro N; Barini E; Spillantini MG; Goedert M; Medini P; Gasparini L
    J Neurosci; 2016 Feb; 36(7):2086-100. PubMed ID: 26888921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective brain-derived neurotrophic factor signaling in the TAU-P301L tauopathy zebrafish model.
    Barbereau C; Yehya A; Silhol M; Cubedo N; Verdier JM; Maurice T; Rossel M
    Pharmacol Res; 2020 Aug; 158():104865. PubMed ID: 32417505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for accelerated tauopathy in the retina of transgenic P301S tau mice exposed to repetitive mild traumatic brain injury.
    Xu L; Ryu J; Nguyen JV; Arena J; Rha E; Vranis P; Hitt D; Marsh-Armstrong N; Koliatsos VE
    Exp Neurol; 2015 Nov; 273():168-76. PubMed ID: 26311071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation in a Tau Transgenic Mouse Model for Alzheimer's Disease: A Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry.
    Schindowski K
    Methods Mol Biol; 2024; 2754():361-385. PubMed ID: 38512677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling.
    Osborne A; Khatib TZ; Songra L; Barber AC; Hall K; Kong GYX; Widdowson PS; Martin KR
    Cell Death Dis; 2018 Sep; 9(10):1007. PubMed ID: 30258047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early alterations of neurovascular unit in the retina in mouse models of tauopathy.
    Xia F; Ha Y; Shi S; Li Y; Li S; Luisi J; Kayed R; Motamedi M; Liu H; Zhang W
    Acta Neuropathol Commun; 2021 Mar; 9(1):51. PubMed ID: 33762004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions.
    Zhu H; Zhang W; Zhao Y; Shu X; Wang W; Wang D; Yang Y; He Z; Wang X; Ying Y
    Mol Neurodegener; 2018 Nov; 13(1):62. PubMed ID: 30466464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.
    Xiang J; Wang ZH; Ahn EH; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Ju G; Wu S; Ye K
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9094-9102. PubMed ID: 31004063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
    Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
    Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APPsα Rescues Tau-Induced Synaptic Pathology.
    Bold CS; Baltissen D; Ludewig S; Back MK; Just J; Kilian L; Erdinger S; Banicevic M; Rehra L; Almouhanna F; Nigri M; Wolfer DP; Spilger R; Rohr K; Kann O; Buchholz CJ; von Engelhardt J; Korte M; Müller UC
    J Neurosci; 2022 Jul; 42(29):5782-5802. PubMed ID: 35667850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7,8-Dihydroxyflavone protects retinal ganglion cells against chronic intermittent hypoxia-induced oxidative stress damage via activation of the BDNF/TrkB signaling pathway.
    Fang YY; Luo M; Yue S; Han Y; Zhang HJ; Zhou YH; Liu K; Liu HG
    Sleep Breath; 2022 Mar; 26(1):287-295. PubMed ID: 33993395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy.
    Arouche-Delaperche L; Cadoni S; Joffrois C; Labernede G; Valet M; César Q; Dégardin J; Girardon S; Gabriel C; Krantic S; Picaud S
    Acta Neuropathol Commun; 2023 Jan; 11(1):5. PubMed ID: 36631898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
    Belrose JC; Masoudi R; Michalski B; Fahnestock M
    Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease.
    Wang ZH; Xiang J; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Wu S; Wang JZ; Ye K
    Cell Rep; 2019 Jul; 28(3):655-669.e5. PubMed ID: 31315045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability.
    Gasparini L; Crowther RA; Martin KR; Berg N; Coleman M; Goedert M; Spillantini MG
    Neurobiol Aging; 2011 Mar; 32(3):419-33. PubMed ID: 19356824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic treatment of behavioral and physiological deficits in a tauopathy mouse model.
    Wang W; Cao Q; Tan T; Yang F; Williams JB; Yan Z
    Aging Cell; 2021 Oct; 20(10):e13456. PubMed ID: 34547169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy.
    Schaeffer V; Lavenir I; Ozcelik S; Tolnay M; Winkler DT; Goedert M
    Brain; 2012 Jul; 135(Pt 7):2169-77. PubMed ID: 22689910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophin receptor TrkB activation is not required for the postnatal survival of retinal ganglion cells in vivo.
    Rohrer B; LaVail MM; Jones KR; Reichardt LF
    Exp Neurol; 2001 Nov; 172(1):81-91. PubMed ID: 11681842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model.
    Burnouf S; Martire A; Derisbourg M; Laurent C; Belarbi K; Leboucher A; Fernandez-Gomez FJ; Troquier L; Eddarkaoui S; Grosjean ME; Demeyer D; Muhr-Tailleux A; Buisson A; Sergeant N; Hamdane M; Humez S; Popoli P; Buée L; Blum D
    Aging Cell; 2013 Feb; 12(1):11-23. PubMed ID: 23082852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.